A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved anti-obesity medications.

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV special focuses on the drugs.

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

"Now, most people will have no symptoms, and the diagnosis is often picked up through a random blood test or a scan. But ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...